High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

导出 OA

翻译打印收藏纠错

作者： D C,Seldin ^[1] ; N,Andrea ; I,Berenbaum ; J L,Berk ; L,Connors ; L M,Dember ; G,Doros ; S,Fennessey ; K,Finn ; S,Girnius ; A,Lerner ; C,Libbey ; H K,Meier-Ewert ; R,O'Connell ; C,O'Hara ; K,Quillen ; F L,Ruberg ; F,Sam ; A,Segal ; A,Shelton ; M,Skinner ; J M,Sloan ; J F,Wiesman ; V,Sanchorawala

作者单位： Clinical Trials Office, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA. ^[1]

主题词淀粉样变性(Amyloidosis);综合疗法(Combined Modality Therapy);剂量效应关系, 药物(Dose-Response Relationship, Drug);人类(Humans);免疫球蛋白轻链(Immunoglobulin Light Chains);干细胞移植(Stem Cell Transplantation);存活率(Survival Rate);移植, 自体(Transplantation, Autologous)

DOI 10.3109/13506129.2011.574354047

PMID 21838459

发布时间 2021-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Amyloid

2011年18 Suppl 1卷

127-9页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

Amyloid

相似文献

Amyloid

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

Amyloid

相似文献

Amyloid

相关期刊

检索历史清除